News & Events

Developed in the VanEpps and Kotov labs, a new machine learning model that predicts interactions between nanoparticles and proteins.

Nick Kotov was named to the American Academy of Arts and Sciences for his significant contributions in scholarly and professional fields.

Collaborative research in the Aguilar lab showed how two of the body’s natural injury responders conflict following traumatic muscle injuries.

Congratulations to Even Keller on joining OVPR as the inaugural Director of Research Cores.

The collaboration developed a new photonic effect which could speed up the development of new antibiotics and drugs through automation.

The Biointerfaces Institute is pleased to welcome our Inaugural Innovation Fellows, Dr. Anastasia Visheratina and Dr. Dylan Neale.

Developed by the Chestek lab, an electrode array implanted in the brain predicts finger motions in near real time.

The new nanoparticle discovery will revolutionize intravenous cancer immunotherapy.

Congratulations to Nick Kotov on winning the 2022 Nanoscale Science and Engineering Forum Award from AIChE for his discovery of chiral nanostructures with large amplitude optical activity and establishing chemical principles for their engineering.

The project is entitled “CAREER: Understanding the Interdependence of the Microenvironment and Nuclear Organization in Stem Cell Aging.”

Lola Eniola-Adefeso named new Associate Dean for Graduate & Professional Education (ADGPE) in the College of Engineering

The BioInnovations in Brain Cancer Initiative (BIBC) at the University of Michigan invites applications for a tenure-track position at any level in brain cancer biology and technology research (including, drug/molecular transport/imaging in the brain tissue; translation-focused glioma, epigenetics and/or scRNA-seq research; and non-viral nucleic acid delivery).

Applications will be accepted on a rolling basis, but review of applications will begin on October 1, 2021.

The Tuteja lab publishes a new review in Science on liquid-repelling surfaces and coatings.

The tiny, implantable carbon fiber electrode developed jointly by Cindy Chestek and Tim Bruns shows promise as a long-term brain-computer interface.

Researchers in the Tessier lab found a simple method for identifying nanobodies with drug-like properties suitable for preventing COVID-19 infections, which likely can be used to develop nanobodies against other viruses and disease targets.